DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 967 filers reported holding DANAHER CORPORATION in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $21,426,479 | -7.1% | 92,619 | -0.4% | 0.72% | -15.6% |
Q3 2023 | $23,062,880 | +5.3% | 92,958 | +1.9% | 0.85% | +8.3% |
Q2 2023 | $21,892,560 | -4.6% | 91,219 | +0.1% | 0.79% | -10.3% |
Q1 2023 | $22,956,811 | +96870.6% | 91,084 | +2.1% | 0.88% | -10.0% |
Q4 2022 | $23,674 | -99.9% | 89,194 | -0.1% | 0.97% | -6.9% |
Q3 2022 | $23,060,000 | +4.3% | 89,279 | +2.4% | 1.05% | +9.3% |
Q2 2022 | $22,101,000 | -9.1% | 87,177 | +5.1% | 0.96% | +4.0% |
Q1 2022 | $24,326,000 | -4.9% | 82,929 | +6.7% | 0.92% | -3.2% |
Q4 2021 | $25,582,000 | +10.8% | 77,754 | +2.5% | 0.95% | -0.4% |
Q3 2021 | $23,085,000 | +10.1% | 75,828 | -2.9% | 0.95% | +7.2% |
Q2 2021 | $20,961,000 | +27.0% | 78,109 | +6.5% | 0.89% | +14.7% |
Q1 2021 | $16,503,000 | +12.3% | 73,322 | +10.8% | 0.78% | +3.1% |
Q4 2020 | $14,697,000 | +5.0% | 66,161 | +1.8% | 0.75% | -7.9% |
Q3 2020 | $13,997,000 | +46.2% | 65,004 | +20.0% | 0.82% | +32.6% |
Q2 2020 | $9,577,000 | +33.9% | 54,158 | +4.8% | 0.62% | +8.1% |
Q1 2020 | $7,150,000 | -10.1% | 51,655 | -0.4% | 0.57% | +16.1% |
Q4 2019 | $7,957,000 | +6.2% | 51,842 | -0.0% | 0.49% | -2.0% |
Q3 2019 | $7,491,000 | +4.1% | 51,867 | +3.0% | 0.50% | +0.8% |
Q2 2019 | $7,195,000 | -99.9% | 50,340 | -1.3% | 0.50% | +2.5% |
Q1 2019 | $6,734,208,000 | +29.1% | 51,009 | +0.8% | 0.49% | +8.7% |
Q4 2018 | $5,217,975,000 | -3.8% | 50,601 | +1.4% | 0.45% | +10.9% |
Q3 2018 | $5,424,959,000 | +13.3% | 49,926 | +2.9% | 0.40% | +5.5% |
Q2 2018 | $4,789,532,000 | -7.7% | 48,536 | -8.5% | 0.38% | -11.2% |
Q1 2018 | $5,191,678,000 | +7.6% | 53,025 | +2.1% | 0.43% | +7.5% |
Q4 2017 | $4,822,834,000 | +8.9% | 51,959 | +0.6% | 0.40% | +9.0% |
Q3 2017 | $4,429,593,000 | +3.5% | 51,639 | +1.9% | 0.37% | -3.7% |
Q2 2017 | $4,277,898,000 | +0.8% | 50,692 | +2.1% | 0.38% | -4.5% |
Q1 2017 | $4,244,854,000 | +11.7% | 49,630 | +1.7% | 0.40% | -14.2% |
Q4 2016 | $3,799,915,000 | -13.6% | 48,817 | +12.2% | 0.46% | -16.4% |
Q2 2016 | $4,396,227,000 | +10.7% | 43,527 | +4.0% | 0.56% | +3.7% |
Q1 2016 | $3,971,693,000 | +8.2% | 41,869 | +6.0% | 0.54% | +2.1% |
Q4 2015 | $3,669,039,000 | +41.7% | 39,503 | +15.9% | 0.52% | -3.8% |
Q3 2015 | $2,588,867,000 | -7.5% | 34,073 | -4.2% | 0.55% | -12.6% |
Q2 2015 | $2,799,954,000 | -11.2% | 35,564 | -4.2% | 0.62% | +20.2% |
Q1 2015 | $3,152,592,000 | +13939.0% | 37,133 | +14072.9% | 0.52% | +7328.6% |
Q4 2014 | $22,456,000 | -99.1% | 262 | -99.2% | 0.01% | -98.6% |
Q3 2014 | $2,588,867,000 | +7017.6% | 34,073 | +7275.1% | 0.52% | +3578.6% |
Q2 2014 | $36,373,000 | +199.4% | 462 | +185.2% | 0.01% | +100.0% |
Q1 2014 | $12,150,000 | – | 162 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |